RETRACTED ARTICLE: Overexpression of interleukins IL-17 and IL-8 with poor prognosis in colorectal cancer induces metastasis
- 882 Downloads
Current evidences indicated that a group of soluble mediators called chemokines is involved in tumor growth and metastasis. The association of IL-8 with tumor cell migration was previously found, and its expression was related to angiogenesis, tumor progression, and metastasis in many kinds of carcinomas in human and animal models. Furthermore, it has been showed that IL-17 plays its role as either a proteome of tumor progression or antitumor indifferent cancer models. To investigate the messenger RNA (mRNA) expressions of IL-8 and IL-17 in patients with colorectal cancer (CRC) and non-tumor tissue, quantitative real-time PCR was used in the study. Our results showed that expression of IL-8 mRNA was significantly increased in tumor tissues (mean ± SD 3.84 ± 0.08) compared with adjacent normal mucosa (mean ± SD 1.17 ± 0.75, P = 0.001). Furthermore, a higher expression of IL-17 mRNA was found in tumor tissues (mean ± SD 2.73 ± 0.69) when compared with normal tissues (mean ± SD 1.06 ± 0.07, P = 0.001). Our findings indicated that advanced tumor-node-metastasis (TNM) stage (P = 0.024) and histological grade (poorly differentiated, P = 0.013) and distant metastasis (P = 0.001) were correlated with expression of IL-8. Moreover, high expression of IL-17 showed significant association with early stage CRC (TNM) (P = 0.038). In conclusion, the expression of IL-8 and IL-17 mRNAs was significantly increased in tumor tissues compared with adjacent normal tissues. We found that advanced TNM stage and histological grade and distant metastasis were correlated with expression of IL-8, while high expression of IL-17 showed significant association with early stage CRC (TNM) stage and overexpression of IL-8 may be associated with progression of CRC.
KeywordsIL-17 IL-8 Colorectal cancer PCR Expression
Compliance with ethical standard
Conflicts of interest
- 2.Ries LAG, Eisner MP. SEER cancer statistics review, 1973–1997. Bethesda: National Cancer Institute; 2000.Google Scholar
- 25.An H, Zhu Y, Xie H, Liu Y, Liu W, Fu Q, Ye D, Xu J. Increased expression of interleukin-8 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma. Tumour Biol. 2015.Google Scholar
- 26.Lurje G, Husain H, Power DG, Yang D, Groshen S, Pohl A, et al. Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinoma. Ann Oncol. 2010;21(1):78–86. doi: 10.1093/annonc/mdp280.
- 32.Mian BM, Dinney CP, Bermejo CE, Sweeney P, Tellez C, Yang XD. Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappab. Clin Cancer Res Off J Am Assoc Cancer Res. 2003;9:3167–75.Google Scholar
- 36.Petanidis S, Anestakis D, Argyraki M, Hadzopoulou-Cladaras M, Salifoglou A. Differential expression of il-17, 22 and 23 in the progression of colorectal cancer in patients with k-ras mutation: ras signal inhibition and crosstalk with GM-CSF and IFN-gamma. PLoS One. 2013;8, e73616.CrossRefPubMedPubMedCentralGoogle Scholar